How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Microsoft Corp. | €430.95 | €501.09 |
| Amazon.com Inc. | €230.00 | €258.42 |
| Intuitive Surgical Inc | €348.10 | €507.75 |
| Security | Price | Target price |
|---|---|---|
| Clorox Co. | €92.42 | €91.19 |
| Western Union Co. | €6.50 | €7.01 |
| Park Hotels & Resorts Inc | €13.10 | €12.57 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Replimune Group Inc | JPMorgan Chase & Co. | 26.40% |
| B FutureFuel Corp. | Traumtanz | 25.73% |
| B Tenax Therapeutics Inc. | daimler1 | 20.61% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Masterbeef Group. | Bankster | -55.93% |
| S Socket Mobile Inc. | Bankster | -43.33% |
| S Socket Mobile Inc. | Lokrim | -19.59% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Space X
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Gigaset AG
WKN: 515600 / Name: Gigaset / Stock / Computers, Phones & Household Electronics / Small Cap /
Pros
Cons
Eastman Kodak
WKN: A1W4RC / Symbol: EKOD / Name: Eastman Kodak / Stock / Computers, Phones & Household Electronics / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Workday, Inc. | €179.20 | 17.540% |
| Sandisk Corp. | €1,330.0 | 13.680% |
| Fiserv Inc. | €48.15 | 8.160% |
| Trade Desk Inc | €12.62 | 7.860% |
| Costar Group Inc. | €28.67 | 7.850% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Tapestry Inc. | €111.35 | -16.170% |
| Cisco Systems Inc. | €98.46 | -8.350% |
| Lumentum Holdings Inc | €763.90 | -5.060% |
| Corning Inc. | €137.54 | -5.060% |
| The Mosaic Co. | €18.90 | -4.660% |
Courses
sharewise Introduction
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Predictions
Packaging Corporation of America
13.08.26
13.08.27
11.08.26
Brinker International Inc.
13.08.26
13.08.27
13.08.26
Telephone & Data Systems Inc.
13.08.26
13.08.27
13.08.26
Top News
Cibus Q2 Earnings Call Highlights
Key Points
- Interested in Cibus, Inc.? Here are five stocks we like better.
- Revenue increased 35% year over year to $2.7 million for the first six months of 2026, while second-quarter net loss
Blaize Q2 Earnings Call Highlights
Key Points
- Interested in Blaize Holdings, Inc.? Here are five stocks we like better.
- Blaize cut its 2026 revenue forecast to $40 million–$43 million, down from $130 million, because of delayed
Cineverse Q1 Earnings Call Highlights
Key Points
- Interested in Cineverse Corp.? Here are five stocks we like better.
- Revenue surged 175% to $30.6 million in fiscal Q1 2027 following the Giant Worldwide and IndiCue acquisitions
EZCORP Eyes Faster Expansion After Record Quarter, SMG Deal
Key Points
- Interested in EZCORP, Inc.? Here are five stocks we like better.
- Record quarterly performance drove EZCORP’s growth, with adjusted EBITDA up 48% and adjusted EPS up 47%. The company
CapsoVision Q2 Earnings Call Highlights
Key Points
- Interested in CapsoVision, Inc.? Here are five stocks we like better.
- Second-quarter revenue rose 10% to $3.6 million, driven by a 13% increase in CapsoCam Plus capsule sales and
Use This Zacks Tool to Find Strong Cloud Stocks
Zacks Thematic Screens lets you dive into 30 dynamic investment themes shaping the future. Whether you're interested in cutting-edge technology, renewable energy, or healthcare innovations, our
Afya (AFYA) Q2 Earnings and Revenues Lag Estimates
Afya (AFYA) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago. These figures are
NextNRG Inc. (NXXT) Reports Q2 Loss, Tops Revenue Estimates
NextNRG Inc. (NXXT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.3 per share a year ago. These figures are
Blaize Holdings, Inc. (BZAI) Reports Q2 Loss, Lags Revenue Estimates
Blaize Holdings, Inc. (BZAI) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.28 per share a year ago. These
RCM Technologies, Inc. (RCMT) Q2 Earnings and Revenues Beat Estimates
RCM Technologies, Inc. (RCMT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.69 per share a year ago
VIQ SOLUTIONS (VQSSF) Q2 Earnings and Revenues Beat Estimates
VIQ SOLUTIONS (VQSSF) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.02 per share a year ago
News
BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Misses Revenue Estimates
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to a loss of $2.45 per share a year ago
Celcuity Q2 Earnings Call Highlights
Key Points
- Interested in Celcuity, Inc.? Here are five stocks we like better.
- REVTORPYK launch remains on track: Celcuity expects commercial shipments of its FDA-approved gedatolisib therapy for
Capricor Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Capricor Therapeutics, Inc.? Here are five stocks we like better.
- FDA review remains ongoing: Capricor plans to amend deramiocel’s application to pursue an upper-limb
AmpliTech Group Q2 Earnings Call Highlights
Key Points
- Interested in AmpliTech Group, Inc.? Here are five stocks we like better.
- Revenue increased 51% sequentially to approximately $8.1 million in Q2 2026, while gross margin improved
XCel Brands (XELB) Reports Q2 Loss, Lags Revenue Estimates
XCel Brands (XELB) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $0.37 per share a year ago. These figures are
Quantum-Si Incorporated (QSI) Reports Q2 Loss, Tops Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.16 per share a year ago. These
TSS Inc. (TSSI) Misses Q2 Earnings and Revenue Estimates
TSS Inc. (TSSI) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.06 per share a year ago. These figures
StoneCo Ltd. (STNE) Q2 Earnings Beat Estimates
StoneCo Ltd. (STNE) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.39 per share a year ago. These
SoundThinking (SSTI) Reports Q2 Loss, Misses Revenue Estimates
SoundThinking (SSTI) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.24 per share a year ago. These figures
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.